ArticleJournal of molecular medicine (Berlin, Germany)2012

RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies.

Stefania Martucciello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.